InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Papadopoulos Stelios, Director. Officer active across 4 companies, notably Exelixis, INC.. Aggregated, 20 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €5.2m. Activity tracked since 11 May 2021. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Papadopoulos Stelios
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
8,367 shares0Common StockSEC:0000939767-26-000083:0
17,578 shares@ US$2.56100.0% of flowCommon StockSEC:0001202098-26-000004:0
100,000 shares@ US$43.5562.6% of flowCommon StockSEC:0000939767-25-000137:0
976,253 sharesCommon StockSEC:0000950170-25-091032:0
9,812 shares0Common StockSEC:0000939767-25-000088:0
20,634 shares@ US$19.7714.9% of flowCommon StockSEC:0000939767-25-000080:0
62,500 shares0Common StockSEC:0000950170-25-061119:0
18,838 shares0Common StockSEC:0000939767-24-000102:0
11,686 shares@ US$19.578.6% of flowCommon StockSEC:0000939767-24-000075:0
250,000 shares@ US$1.6018.6% of flowCommon StockSEC:0000950170-24-032213:0
20,718 shares0Common StockSEC:0000939767-23-000056:0
222,198 shares@ US$0.90019.2% of flowCommon StockSEC:0001209191-23-024329:0
2,255 shares0Common StockSEC:0001127602-22-017806:0
19,575 shares0Common StockSEC:0000939767-22-000079:0
84,515 shares@ US$19.560.013% mcap77.9% of flowCommon StockSEC:0000939767-22-000031:0
2,222,222 shares@ US$0.3656.5% of flowCommon StockSEC:0001209191-21-067264:0
1,275 shares0Common StockSEC:0001127602-21-021336:0
16,424 shares0Common StockSEC:0000939767-21-000063:0
40,000 shares@ US$6.303.5% of flowCommon StockSEC:0000939767-21-000049:0
15,071 sharesCommon StockSEC:0000939767-16-000129:0
20 of 20 declarations
About Papadopoulos Stelios
Administrateur, a declarant with 20 filings in total. Among the sampled recent filings from 2016-01-05 to 2026-05-29, sells total EUR 5220048, with no buys reported, and the modal transaction nature is Attribution. The main filings concern Exelixis, INC., Regulus Therapeutics Inc., BIOGEN INC. and Ovid Therapeutics Inc.
